- Home
- SJT vs SLRN Comparison
SJT vs SLRN Comparison
Compare SJT & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SJT
- SLRN
- Stock Information
- Founded
- SJT 1980
- SLRN 2020
- Country
- SJT United States
- SLRN United States
- Employees
- SJT N/A
- SLRN N/A
- Industry
- SJT Oil & Gas Production
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- SJT Energy
- SLRN Health Care
- Exchange
- SJT Nasdaq
- SLRN Nasdaq
- Market Cap
- SJT 227.0M
- SLRN 224.6M
- IPO Year
- SJT N/A
- SLRN 2023
- Fundamental
- Price
- SJT $5.76
- SLRN $2.34
- Analyst Decision
- SJT
- SLRN Hold
- Analyst Count
- SJT 0
- SLRN 5
- Target Price
- SJT N/A
- SLRN $9.60
- AVG Volume (30 Days)
- SJT 259.8K
- SLRN 970.9K
- Earning Date
- SJT 05-13-2025
- SLRN 05-12-2025
- Dividend Yield
- SJT 0.40%
- SLRN N/A
- EPS Growth
- SJT N/A
- SLRN N/A
- EPS
- SJT 0.11
- SLRN N/A
- Revenue
- SJT $7,032,254.00
- SLRN N/A
- Revenue This Year
- SJT N/A
- SLRN $267.11
- Revenue Next Year
- SJT N/A
- SLRN N/A
- P/E Ratio
- SJT $51.23
- SLRN N/A
- Revenue Growth
- SJT N/A
- SLRN N/A
- 52 Week Low
- SJT $3.21
- SLRN $1.85
- 52 Week High
- SJT $5.94
- SLRN $7.25
- Technical
- Relative Strength Index (RSI)
- SJT 61.70
- SLRN 47.95
- Support Level
- SJT $5.04
- SLRN $2.17
- Resistance Level
- SJT $5.94
- SLRN $2.32
- Average True Range (ATR)
- SJT 0.31
- SLRN 0.18
- MACD
- SJT 0.05
- SLRN -0.00
- Stochastic Oscillator
- SJT 87.05
- SLRN 33.88
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.